Dexmedetomidine protects against lidocaine-induced neurotoxicity through SIRT1 downregulation-mediated activation of FOXO3a.

MLA

Zheng, L. N., et al. “Dexmedetomidine Protects against Lidocaine-Induced Neurotoxicity through SIRT1 Downregulation-Mediated Activation of FOXO3a.” Human & Experimental Toxicology, vol. 39, no. 9, Sept. 2020, pp. 1213–23. EBSCOhost, https://doi.org/10.1177/0960327120914971.

APA

Zheng, L.-N., Guo, F.-Q., Li, Z.-S., Wang, Z., Ma, J.-H., Wang, T., Wei, J.-F., & Zhang, W.-W. (2020). Dexmedetomidine protects against lidocaine-induced neurotoxicity through SIRT1 downregulation-mediated activation of FOXO3a. Human & Experimental Toxicology, 39(9), 1213–1223. https://doi.org/10.1177/0960327120914971

Chicago

Zheng, L-N, F-Q Guo, Z-S Li, Z Wang, J-H Ma, T Wang, J-F Wei, and W-W Zhang. 2020. “Dexmedetomidine Protects against Lidocaine-Induced Neurotoxicity through SIRT1 Downregulation-Mediated Activation of FOXO3a.” Human & Experimental Toxicology 39 (9): 1213–23. doi:10.1177/0960327120914971.